Bank of New York Mellon Corp
BankPosition in CHRS — Coherus Oncology, Inc.
CIK 1390777
NEW YORK, NY
Position in CHRS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$447,560
-$34,144 QoQ
Shares Held
319,687
+12.2% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. CHRS ranks #249 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in CHRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $447,560 | 319,687 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $481,704 | 285,033 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $413,024 | 290,863 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $617,762 | 376,685 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $285,318 | 390,313 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $314,019 | 389,121 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $539,582 | 391,002 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $321,130 | 308,780 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $673,358 | 389,225 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $738,516 | 309,003 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,179,721 | 354,271 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,479,268 | 395,527 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,519,502 | 590,048 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,836,554 | 560,900 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $4,588,909 | 579,408 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,995,589 | 623,891 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,194,210 | 579,311 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,707,848 | 597,045 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $11,320,170 | 709,284 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,086,939 | 814,371 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $10,940,896 | 791,099 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $12,120,819 | 829,625 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $14,325,219 | 824,236 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $13,024,442 | 710,166 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,594,082 | 705,156 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $4,492,062 | 276,946 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||